Skip to main content

Rare Autoimmune Diseases

  • Chapter
  • First Online:
Rare Diseases Epidemiology

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 686))

  • 2739 Accesses

Abstract

Under the term “autoimmune diseases” are comprised a large number of disorders with variable clinical expression which have in common an autoimmune pathogenesis as defined by direct, indirect or circumstantial evidence. Autoimmune diseases may affect a single organ or may determine a multisystem involvement, and most of them cause significant and chronic morbidity and disability. Another important feature of autoimmune diseases is their propensity to affect more often females than males. Although few of them are quite common and well studied, the majority of autoimmune diseases are rare, and share with rare diseases lack of epidemiology data. The implementation of specific disease registries can help improve the knowledge on epidemiology of these conditions, a crucial step for evaluating health care interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

References

  1. Burman KD, Baker JR Jr (1985) Immune mechanisms in Graves’ disease. Endocr Rev 6:183

    Article  PubMed  CAS  Google Scholar 

  2. Cooper GS, Stroehla BC (2003) The epidemiology of autoimmune diseases. Autoimmunity Rev 2:119–125

    Article  Google Scholar 

  3. Cooper GS, Bynum ML, Somers EC (2009) Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 33:197–207

    Article  PubMed  Google Scholar 

  4. Davidson A, Diamond B (2001) Autoimmune diseases. N Engl J Med 345:340–350

    Article  PubMed  CAS  Google Scholar 

  5. Drachman DB (1990) How to recognize an antibody-mediated autoimmune disease: Criteria. In: Waksman BH (ed) Immunologic mechanisms in neurologic and psychiatric disease, Raven, New York, p 183

    Google Scholar 

  6. Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB (2007) Epidemiology of autoimmune diseases in Denmark. J Autoimmun 29:1–9

    Article  PubMed  Google Scholar 

  7. Engelberg AB, Kesselheim AS, Avorn J (2009) Balancing innovation, access, and profits – market exclusivity for biologics. N Engl J Med 361:1917–1919

    Article  PubMed  CAS  Google Scholar 

  8. Gleicher N, Barad DH (2007) Gender as risk factor for autoimmune diseases. J Autoimmun 28:1–6

    Article  PubMed  CAS  Google Scholar 

  9. Jacobson DL, Gange SJ, Rose NR, Graham NM (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84:223–243

    Article  PubMed  CAS  Google Scholar 

  10. Kavanaugh A (2007) Economic consequences of established rheumatoid arthritis and its treatment. Best Pract Res Clin Rheumatol 21:929–942

    Article  PubMed  Google Scholar 

  11. Lau CS, Mak A (2009) The socioeconomic burden of SLE. Nat Rev Rheumatol 5:400–404

    Article  PubMed  Google Scholar 

  12. Ramos-Casals M, Brito-Zerón P, Muñoz S, Soto MJ; BIOGEAS STUDY Group (2008) A systematic review of the off-label use of biological therapies in systemic autoimmune diseases. Medicine (Baltimore) 87:345–364

    Article  Google Scholar 

  13. Reichlin M, Brucato A, Frank MB, Maddison PJ, McCubbin VR, Wolfson-Reichlin M, Lee LA (1994) Concentration of autoantibodies to native 60-kd Ro/SS-A and denatured 52-kd Ro/SS-A in eluates from the heart of a child who died with congenital complete heart block. Arthritis Rheum 37:1698–1703

    Article  PubMed  CAS  Google Scholar 

  14. Rose NR, Bona C (1993) Defining criteria for autoimmune diseases (Witebsky’s postulates revised). Immunol Today 14:426–430

    Article  PubMed  CAS  Google Scholar 

  15. Rose NR (1997) Autoimmune diseases: tracing the shared threads. Hosp Pract (Off Ed) 32:147–154

    Google Scholar 

  16. Schieppati A, Henter JI, Daina E, Aperia A (2008) Why rare diseases are an important medical and social issue. Lancet 371:2039–2041

    Article  PubMed  Google Scholar 

  17. Shiina T, Inoko H, Kulski JK (2004) An update of the HLA genomic region, locus information and disease associations. Tissue Antigens 64: 631–64

    Article  PubMed  CAS  Google Scholar 

  18. Theofilopoulos AN (1993) Immunologic genes in mouse lupus models. In: Bona CA, Siminovich KA, Zanetti M, Theofilopoulos AN (eds) The molecular pathology of autoimmune diseases, Harwood, Chur, Switzerland, p 281

    Google Scholar 

  19. Walsh SJ, Rau LM (2000) Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health 90:1463–6

    Article  PubMed  CAS  Google Scholar 

  20. Whitacre CC (2001) Sex differences in autoimmune disease. Nat Immunol 2:777–780

    Article  PubMed  CAS  Google Scholar 

  21. World Health Organization (2009) ICD Revision Topic Advisory Groups http://www.who.int/classifications/icd/TAGs/en/index.html

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arrigo Schieppati MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Netherlands

About this chapter

Cite this chapter

Schieppati, A., Daina, E. (2010). Rare Autoimmune Diseases. In: Posada de la Paz, M., Groft, S. (eds) Rare Diseases Epidemiology. Advances in Experimental Medicine and Biology, vol 686. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9485-8_21

Download citation

Publish with us

Policies and ethics